Expand all sections

Omalizumab

STI-004

Extended indication Aanvullende behandeling om de astmacontrole te verbeteren bij patiënten met ernstig persistent aller
Therapeutic value Possible equal value
Registration phase Clinical trials

Product

Registration

Therapeutic value

Expected patient volume per year

Expected cost per patient per year

Potential total cost per year

Off label use

Indication extension

Other information